A new oral weight loss pill shows results similar to Ozempic and Wegovy injections in the treatment of obesity.

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

The drug is still going through trials, but the medical company Lilly, behind it, is hopeful it can be rolled out soon. In ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

In some cases, your doctor may suggest changing your Wegovy dosage or taking a different weight loss drug, such as tirzepatide (Zepbound). Wegovy is a long-term treatment that you may use to ...

Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

(AP Photo/Susan Haigh) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] States increasingly struggling to ...

Shares of weight-loss drugmakers Novo Nordisk A/S and Eli Lilly and Co. got a nice lift Monday, after a potential competitor decided to cancel development of its GLP-1 obesity drug. “We continue ...